Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Pforzheim

10 clinical trials in Pforzheim, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Pforzheim at a glance
10
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Pforzheim

Open in trial search

Crohn's disease

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Coeliac disease

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Crohn's disease

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Crohn's disease

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Pforzheim

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Comprehensive studies focusing on Crohn's disease and ulcerative colitis, evaluating innovative therapeutic approaches for patients with moderate to severe symptoms.

  • Novel Treatment Evaluation
  • Long-term Disease Management
  • Treatment Resistance Studies

Multiple clinical trials examining the efficacy of emerging medications for patients who haven't responded to conventional therapies.

02 Crohn's Disease Studies

Dedicated research investigating new therapeutic options for moderately to severely active Crohn's disease, with particular attention to treatment-resistant cases.

  • Induction Therapy Assessment
  • Maintenance Treatment Protocols
  • Long-term Safety Monitoring

Research focused on both short-term symptom improvement and sustained disease control.

03 Ulcerative Colitis Trials

Extensive clinical research targeting moderate to severe ulcerative colitis, evaluating new therapeutic compounds for improved disease management.

  • Endoscopic Improvement Studies
  • Symptomatic Remission Research
  • Extended Safety Assessments

Trials designed to assess both clinical remission and long-term treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.